Successful behavior changes in a man with hypertensionHOLLENBERG, N. K.Cardiovascular reviews & reports. 1988, Vol 9, Num 5, pp 30-31, issn 0197-3118Article

Proceedings potassium, magnesium and cardiovascular morbidity. Symposium, November 10, 1985 Washington DCHOLLENBERG, N. K.The American journal of medicine. 1986, Vol 80, Num 4A, issn 0002-9343, 35 p.Conference Proceedings

Differential pressor and renal vascular reactivity to angiotensin II in spontaneously hypertensive and Wistar-Kyoto ratsGUIDI, E; HOLLENBERG, N. K.Hypertension (Dallas, Tex. 1979). 1987, Vol 9, Num 6, pp 591-597, issn 0194-911XArticle

Hypertension and the kidney : determinants of the response to antihypertensive therapy and their implicationsHOLLENBERG, N. K.The American heart journal. 1993, Vol 125, Num 2, pp 604-608, issn 0002-8703, 2Conference Paper

Hyperkalemia in diabetes mellitus: effect of a triamterene-hydrochlorothiazide combinationHOLLENBERG, N. K; MICKIEWICZ, C.Archives of internal medicine (1960). 1989, Vol 149, Num 6, pp 1327-1330, issn 0003-9926Article

Proceedings/Experience, progress, and clinical perspectives on angiotensin converting enzyme inhibition, symposium, San Diego CA, May 3, 1987HOLLENBERG, N. K.The American journal of medicine. 1988, Vol 84, Num 4, issn 0002-9343, 46 p., suppl. AConference Proceedings

Proceedings/Calcium channel blockers, new insights into their role in the management of hypertension, symposium: 10th. world congress of cardiology, Washington DC, September 13, 1986HOLLENBERG, N. K.The American journal of medicine. 1987, Vol 82, Num 3, issn 0002-9343, 41 p., suppl. BConference Proceedings

Vasomotion of renal blood flow in essential hypertension: oscillations in xenon transitHOLLENBERG, N. K; SANDOR, T.Hypertension (Dallas, Tex. 1979). 1984, Vol 6, Num 4, pp 579-585, issn 0194-911XArticle

Angiotensin-converting enzyme inhibition and renal protection : an assessment of implications for therapyHOLLENBERG, N. K; RAIJ, L.Archives of internal medicine (1960). 1993, Vol 153, Num 21, pp 2426-2435, issn 0003-9926Article

Effect of CLS 2210 (calcium dobesilate) on survival and myocardial infarction size in the rat : influence of dose and duration of treatmentHUTTL, K; HOLLENBERG, N. K.Cardiology. 1992, Vol 80, Num 1, pp 28-33, issn 0008-6312Article

Centripetal spread of arterial collateral endothelial cell hyperplasia after renal artery stenosis in the ratHOLLENBERG, N. K; ODORI, T.Circulation research. 1987, Vol 60, Num 3, pp 398-401, issn 0009-7330Article

Proceedings/Renal function and hemodynamics in hypertension: therapeutic considerations, symposium, Miami FL, November 11, 1984HOLLENBERG, N. K.The American journal of medicine. 1985, Vol 79, Num 3, issn 0002-9343, 41 p., CConference Proceedings

Non-modulating hypertension : a subset of sodium-sensitive hypertensionWILLIAMS, G. H; HOLLENBERG, N. K.Hypertension (Dallas, Tex. 1979). 1991, Vol 17, Num 1, pp I81-I85, issn 0194-911X, SUPConference Paper

Management of hypertension and cardiovascular riskHOLLENBERG, N. K.The American journal of medicine. 1991, Vol 90, Num 2A, pp 2A.2S-2A, issn 0002-9343, -6SConference Paper

Specific increase in sensitivity to serotonin of the canine hindlimb collateral arterial tree via the 5-hydroxytryptamine-2-receptorORLANDI, C; BLACKSHEAR, J. L; HOLLENBERG, N. K et al.Microvascular research (Print). 1986, Vol 32, Num 1, pp 121-130, issn 0026-2862Article

Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremiaDZAU, V. J; HOLLENBERG, N. K.Annals of internal medicine. 1984, Vol 100, Num 6, pp 777-782, issn 0003-4819Article

Endogenous sodium pump inhibition : Current status and therapeutic opportunitiesHOLLENBERG, N. K; GRAVES, S. W.Progress in drug research. 1996, Vol 46, pp 9-42, issn 0071-786XArticle

Hypertension in an aging population : problems and opportunitiesHOLLENBERG, N. K.The American journal of medicine. 1991, Vol 90, Num 4B, pp 4B.1S-4B.2S, issn 0002-9343Conference Paper

Myocardial infarction treated with two lymphagogues, calcium dobesilate (CLS 2210) and hyaluronidase : a coded, placebo-controlled animal studyREPA, I; GARNIC, J. D; HOLLENBERG, N. K et al.Journal of cardiovascular pharmacology. 1990, Vol 16, Num 2, pp 286-291, issn 0160-2446, 6 p.Article

Time course of enhanced adrenal responsiveness to angiotensin on an low salt dietROGACZ, S; WILLIAMS, G. H; HOLLENBERG, N. K et al.Hypertension (Dallas, Tex. 1979). 1990, Vol 15, Num 4, pp 376-380, issn 0194-911X, 5 p.Article

Goals of antihypertensive therapy: what really counts? Symposium, Atlanta GA, March 26, 1988HOLLENBERG, N. K.The American journal of cardiology. 1989, Vol 63, Num 4, issn 0002-9149, 41 p., suppl. BConference Proceedings

Quality of life as a therapeutic end-point: an analysis of therapeutic trials in hypertensionHOLLENBERG, N. K; TESTA, M; WILLIAMS, G. H et al.Drug safety. 1991, Vol 6, Num 2, pp 83-93, issn 0114-5916, 11 p.Article

Protection against acute renal failure by prior acute renal failure: differences between myohemoglobinuric and ischemic modelsWILKES, B. M; HOLLENBERG, N. K.Nephron. 1987, Vol 47, Num 3, pp 220-226, issn 0028-2766Article

Regional hemodynamics following captopril therapy. Symposium held at Strasbourg, September 1-2, 1983HOLLENBERG, N. K; RAPAPORT, E; SLEIGHT, P et al.The American journal of medicine. 1984, Vol 76, Num 5B, issn 0002-9343, VI-119 pConference Proceedings

Implications of species difference for clinical investigation : Studies on the renin-angiotensin systemHOLLENBERG, N. K.Hypertension (Dallas, Tex. 1979). 2000, Vol 35, Num 1, pp 150-154, issn 0194-911X, 2Article